Javascript must be enabled to continue!
Troponin and non-traumatic subarachnoid haemorrhage
View through CrossRef
Introduction: Subarachnoid haemorrhage (SAH) is a devastating event, with a mortality of up to 50%. Acute cardiac dysfunction is common after such an event, and it is known to have a negative impact on the outcome of these patients. Cardiac troponin release occurs frequently after SAH and represents an early biomarker for neurogenic cardiac dysfunction.
Objective: The present study aimed to evaluate the impact of a raised troponin value on the outcome of SAH patients.
Methods: This is a prospective observational study held between 2014-2017 at the University Emergency Hospital, Bucharest. Data on clinical admission status, high-sensitivity troponin I, ECG and echocardiographic evaluation results, ICU length of stay and in-hospital mortality rate. Statistical analysis was performed using non-parametrical Mann-Whitney and chi-square tests. The results were considered significant at p<0.05.
Results: A total of 335 consecutive patients with non-traumatic SAH were admitted during the study period. 92 of them were excluded and 243 were analyzed, 203 with aneurysmal SAH and 40 with non-aneurysmal, non-traumatic SAH. High-sensitivity troponin I reached its peak level 48 to 72 hours after SAH and was higher in patients with aneurysmal SAH. For all SAH patients, its median and peak values on days 1 and 2 were correlated with the ICU length of stay and inversely correlated with in-hospital length of stay. For the first 3 days, the median and maximum troponin values are higher in patients who died compared with those who survived and were discharged home (p-value < 0.001). Predictors of an elevated troponin on day 1 are loss of consciousness at ictus, a high Hunt and Hess and Fisher Scale grade, intraventricular haemorrhage and cerebral midline shift.
Conclusions: The release of cardiac troponin is a valuable marker of neurogenic cardiac dysfunction in the first 3 days after SAH. The study replicates other data in the literature and highlights the association between SAH severity, early troponin elevation and in-hospital death.
Romanian Society of Neurosurgery
Title: Troponin and non-traumatic subarachnoid haemorrhage
Description:
Introduction: Subarachnoid haemorrhage (SAH) is a devastating event, with a mortality of up to 50%.
Acute cardiac dysfunction is common after such an event, and it is known to have a negative impact on the outcome of these patients.
Cardiac troponin release occurs frequently after SAH and represents an early biomarker for neurogenic cardiac dysfunction.
Objective: The present study aimed to evaluate the impact of a raised troponin value on the outcome of SAH patients.
Methods: This is a prospective observational study held between 2014-2017 at the University Emergency Hospital, Bucharest.
Data on clinical admission status, high-sensitivity troponin I, ECG and echocardiographic evaluation results, ICU length of stay and in-hospital mortality rate.
Statistical analysis was performed using non-parametrical Mann-Whitney and chi-square tests.
The results were considered significant at p<0.
05.
Results: A total of 335 consecutive patients with non-traumatic SAH were admitted during the study period.
92 of them were excluded and 243 were analyzed, 203 with aneurysmal SAH and 40 with non-aneurysmal, non-traumatic SAH.
High-sensitivity troponin I reached its peak level 48 to 72 hours after SAH and was higher in patients with aneurysmal SAH.
For all SAH patients, its median and peak values on days 1 and 2 were correlated with the ICU length of stay and inversely correlated with in-hospital length of stay.
For the first 3 days, the median and maximum troponin values are higher in patients who died compared with those who survived and were discharged home (p-value < 0.
001).
Predictors of an elevated troponin on day 1 are loss of consciousness at ictus, a high Hunt and Hess and Fisher Scale grade, intraventricular haemorrhage and cerebral midline shift.
Conclusions: The release of cardiac troponin is a valuable marker of neurogenic cardiac dysfunction in the first 3 days after SAH.
The study replicates other data in the literature and highlights the association between SAH severity, early troponin elevation and in-hospital death.
Related Results
Additional PKA phosphorylation sites in human cardiac troponin I
Additional PKA phosphorylation sites in human cardiac troponin I
We used mass spectrometry to monitor cAMP‐dependent protein kinase catalysed phosphorylation of human cardiac troponin I in vitro. Phosphorylation of isolated troponin I by cAMP‐de...
Phosphorylation of troponin and the effects of interactions between the components of the complex
Phosphorylation of troponin and the effects of interactions between the components of the complex
1. The troponin complex from skeletal muscle contains approximately 1 mol of phosphate/80000g of complex, covalently bound to the troponin T component. 2. On prolonged incubation o...
Structural dynamics of the intrinsically disordered linker region of cardiac troponin T
Structural dynamics of the intrinsically disordered linker region of cardiac troponin T
ABSTRACT
The cardiac troponin complex, composed of troponins I, T, and C, plays a central role in regulating the calcium-dependent interactions between myosin and t...
Misleading Elevation of Troponin T caused by Polymyositis
Misleading Elevation of Troponin T caused by Polymyositis
Background: Elevations of cardiac enzymes are commonly used to indicate myocardial ischemia, but they can be elevated due to other conditions. Different forms of Troponin (cTnT, sT...
The phosphorylation of troponin I from cardiac muscle
The phosphorylation of troponin I from cardiac muscle
1. Troponin I isolated from fresh cardiac muscle by affinity chromatography contains about 1.9 mol of covalently bound phosphate/mol. Similar preparations of white-skeletal-muscle ...
Analysis of the causes of discrepancies in troponin I concentrations as measured by ARCHITECT High-Sensitive Troponin I ST and STACIA CLEIA cTnI
Analysis of the causes of discrepancies in troponin I concentrations as measured by ARCHITECT High-Sensitive Troponin I ST and STACIA CLEIA cTnI
Background
Recently developed reagents for the highly sensitive measurement of cardiac troponin I are useful for early diagnosis of acute coronary syndrome. How...
TROPONIN IS INDEPENDENTLY ASSOCIATED WITH DEATH IN PATIENTS WITH COVID: A RETROSPECTIVE STUDY
TROPONIN IS INDEPENDENTLY ASSOCIATED WITH DEATH IN PATIENTS WITH COVID: A RETROSPECTIVE STUDY
Abstract
Objective
We performed a single-centre retrospective observational study investigating the association between troponi...
Prevalence and Outcomes of Cardiovascular Diseases in Patients with COVID-19: A Research Letter
Prevalence and Outcomes of Cardiovascular Diseases in Patients with COVID-19: A Research Letter
Introduction
A higher prevalence of cardiovascular diseases among COVID-19 with positive troponin levels was initially observed in China beginning of the pandemic era. We are tryin...

